Medoc Ltd., established in 1990, is a leading developer and manufacturer of neuro-diagnostic medical systems used to evaluate the function of small and large peripheral sensory nerve fibers.
Following growing interest in using Medoc devices in pharma-sponsored multi-center analgesic clinical-trials.
Main reasons to use Medoc devices are stratifying patients to predict treatment response (i.e. 'Phenotyping') and as secondary efficacy and safety outcome measures. Given the relative complex nature of the test procedures and based on Medoc experience in such recent projects, Medoc has developed services and offerings aimed to seamlessly integrate the testing procedures and to support quality data collection.